Anant Agrawal

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Quantitative evaluation of optical coherence tomography signal enhancement with gold nanoshells
    Anant Agrawal
    US Food and Drug Administration, Center for Devices and Radiological Health, Optical Diagnostics Laboratory, 12725 Twinbrook Parkway, HFZ 130, Rockville, Maryland 20852, USA
    J Biomed Opt 11:041121. 2006
  2. ncbi Three-dimensional characterization of optical coherence tomography point spread functions with a nanoparticle-embedded phantom
    Anant Agrawal
    Optical Diagnostic Devices Laboratory, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Opt Lett 35:2269-71. 2010
  3. ncbi Evaluation of a fiberoptic-based system for measurement of optical properties in highly attenuating turbid media
    Divyesh Sharma
    Food and Drug Administration, Center for Devices and Radiological Health, Rockville, Maryland, USA
    Biomed Eng Online 5:49. 2006
  4. ncbi Oblique-incidence illumination and collection for depth-selective fluorescence spectroscopy
    T Joshua Pfefer
    Food and Drug Administration FDA CDRH HFZ 130, Center for Devices and Radiological Health, 12725 Twinbrook Parkway, Rockville, Maryland 20852, USA
    J Biomed Opt 10:44016. 2005
  5. ncbi Fluoroquinolone antibiotics having the potential to interfere with fluorescence-based diagnosis
    L Stephanie Matchette
    FDA CDRH, Silver Spring, MD, USA
    Photochem Photobiol 83:1386-93. 2007
  6. ncbi Measurement of internal tissue optical properties at ultraviolet and visible wavelengths: Development and implementation of a fiberoptic-based system
    Quanzeng Wang
    Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, Maryland 20993, USA
    Opt Express 16:8685-703. 2008
  7. ncbi Simultaneous detection and semiquantification of DNA damage in normal and apoptotic cells: triple-immunofluorescent labeling using DAPI, antibodies, and TUNEL
    Anant Agrawal
    US Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, MD 20993 0002, USA
    Appl Immunohistochem Mol Morphol 20:402-9. 2012

Collaborators

Detail Information

Publications7

  1. ncbi Quantitative evaluation of optical coherence tomography signal enhancement with gold nanoshells
    Anant Agrawal
    US Food and Drug Administration, Center for Devices and Radiological Health, Optical Diagnostics Laboratory, 12725 Twinbrook Parkway, HFZ 130, Rockville, Maryland 20852, USA
    J Biomed Opt 11:041121. 2006
    ..Quantitative experimental data presented here will facilitate optimization of OCT-based diagnostics and may also be relevant to other reflectance-based approaches as well...
  2. ncbi Three-dimensional characterization of optical coherence tomography point spread functions with a nanoparticle-embedded phantom
    Anant Agrawal
    Optical Diagnostic Devices Laboratory, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Opt Lett 35:2269-71. 2010
    ..Results indicate submicrometer agreement with conventional approaches to measure dimensions of the PSF. The NEP offers a robust approach for validating and comparing imaging performance of OCT devices...
  3. ncbi Evaluation of a fiberoptic-based system for measurement of optical properties in highly attenuating turbid media
    Divyesh Sharma
    Food and Drug Administration, Center for Devices and Radiological Health, Rockville, Maryland, USA
    Biomed Eng Online 5:49. 2006
    ..The influence of collecting reflectance at the illumination fiber on estimation accuracy is also investigated...
  4. ncbi Oblique-incidence illumination and collection for depth-selective fluorescence spectroscopy
    T Joshua Pfefer
    Food and Drug Administration FDA CDRH HFZ 130, Center for Devices and Radiological Health, 12725 Twinbrook Parkway, Rockville, Maryland 20852, USA
    J Biomed Opt 10:44016. 2005
    ....
  5. ncbi Fluoroquinolone antibiotics having the potential to interfere with fluorescence-based diagnosis
    L Stephanie Matchette
    FDA CDRH, Silver Spring, MD, USA
    Photochem Photobiol 83:1386-93. 2007
    ..The product of the drug tissue concentration and quantum yield, which we term the fluorescence effective concentration, is such that it is likely these fluoroquinolones will interfere during fluorescence diagnosis techniques...
  6. ncbi Measurement of internal tissue optical properties at ultraviolet and visible wavelengths: Development and implementation of a fiberoptic-based system
    Quanzeng Wang
    Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, Maryland 20993, USA
    Opt Express 16:8685-703. 2008
    ..This system provides a high level of accuracy over a wide range of optical properties, and should be particularly useful for in situ characterization of highly attenuating biological tissues in the UVA-VIS...
  7. ncbi Simultaneous detection and semiquantification of DNA damage in normal and apoptotic cells: triple-immunofluorescent labeling using DAPI, antibodies, and TUNEL
    Anant Agrawal
    US Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, MD 20993 0002, USA
    Appl Immunohistochem Mol Morphol 20:402-9. 2012
    ..Scientists can now create beautiful fluorescent pictures that simultaneously detect DNA damage in both normal and apoptotic cells to assess and semiquantify the damage to understand better how different insults lead to the cell's demise...